Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
12/2012
12/25/2012US8338603 TRPV1 antagonists
12/25/2012US8338450 Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors
12/25/2012US8338449 Isoquinolinone potassium channel inhibitors
12/25/2012US8338446 Peripheral opioid receptor antagonists and uses thereof
12/25/2012US8338337 Substituted pyridines having a herbicidal effect
12/20/2012US20120319087 Heterocyclic compound and organic light-emitting device containing same
12/20/2012US20120319086 Condensed-cyclic compound and organic light emitting diode comprising the same
12/20/2012DE102012202012A1 Heterocyclische Verbindung und diese enthaltende organische lichtemittierende Anzeige Heterocyclic compound, and this organic light emitting display containing
12/19/2012EP2535332A1 Sinomenine derivatives, synthetic methods and uses thereof
12/19/2012EP2535331A1 Condensed-Cyclic Compound and Organic Light-Emitting Diode Comprising the Same
12/19/2012EP2535329A2 Spiro-piperidine derivatives
12/19/2012CN102827079A Method of synthesizing varenicline intermediate 2,3,4,5-tetrahydro-1,5-methano-1H-3-benzo azepine hydrochloride
12/19/2012CN102827078A Condensed-cyclic compound and organic light-emitting diode comprising the same
12/19/2012CN102827077A Preparation method for phenanthridine derivative
12/19/2012CN102093289B New preparation method of Blonanserin intermediate
12/18/2012US8334303 Specifically mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate (SB 268091); use as antibiotic; crystallization from isopropanol; improved bioavailability, and/or physical properties, for example solubility or flow properties
12/18/2012US8334298 Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopamine agonist
12/18/2012US8334029 Materials and methods for the preparation of anisotropically-ordered solids
12/13/2012US20120316343 Reductive Amination of 6-Keto Morphinans by Catalytic Hydrogen Transfer
12/13/2012US20120316342 Therapeutic agent for hepatitis c
12/13/2012US20120316159 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
12/12/2012EP2532652A1 Therapeutic agent for hepatitis c
12/12/2012CN101454288B Benzofluoranthene compound and organic light-emitting element using the same
12/11/2012US8329906 Guanidinyl-substituted hydroxy-6-phenylphenanthridines
12/11/2012US8329377 Imide compound and chemically amplified resist composition containing the same
12/11/2012CA2483890C Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/06/2012US20120309759 Screening Method and Compounds for Modulating Telomerase Activity
12/06/2012US20120308589 Sinomenine derivatives, synthetic methods and uses thereof
12/05/2012EP2528890A1 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators
12/05/2012EP2528440A1 Substituted norindenoisoquinolines, syntheses thereof, and methods of use
12/05/2012CN102812007A Therapeutic agent for hepatitis C
12/05/2012CN102807527A Anthracene pyridone compound and preparation method and application thereof
11/2012
11/29/2012WO2012160182A1 Polymer-bonded quaterrylene and/or terrylene dyes and compositions containing same
11/29/2012WO2012159213A1 Compounds with oxime ester and/or acyl groups
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012CA2836817A1 Compounds with oxime ester and/or acyl groups
11/29/2012CA2835722A1 Polymer-bonded quaterrylene and/or terrylene dyes and compositions containing same
11/28/2012CN102803224A Novel azabicyclohexanes
11/28/2012CN101747272B Crystal form B of blonanserin and preparing method thereof
11/27/2012US8318937 Preparation of opiate analgesics by reductive alkylation
11/27/2012CA2643400C Camptothecin derivatives and their uses
11/22/2012US20120295923 Aminocyclohexanes and Aminotetrahydropyrans and Related Compounds As Gamma-Secretase Modulators
11/22/2012US20120295856 Fredericamycin derivatives
11/22/2012US20120294808 Fluorescent Analogs of Neurotransmitters, Compositions Containing the Same and Methods of Using the Same
11/21/2012EP2524914A1 Novel sulfonic acid derivative compound and novel naphthalic acid derivative compound
11/21/2012CN102786472A Method for extraction separation of huperzine A in all-grass of snake foot clubmoss and its hairy root by supercritical extraction-crystallization technology
11/21/2012CN102397267B Method for preparing sinomenine hydrochloride cataplasma
11/21/2012CN102206181B Method for preparing norisoboldine
11/20/2012US8314119 Azaadamantane derivatives and methods of use
11/20/2012CA2611530C Tyrosine kinase inhibitors
11/15/2012US20120289702 Nitrogen-containing heterocyclic compound and agricultural fungicide
11/15/2012US20120289697 Novel sulfonic acid derivative compound and novel naphthalic acid derivative compound
11/14/2012EP2522670A1 Heterocyclic CRF receptor antagonists
11/14/2012EP2522658A1 Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
11/14/2012EP2521711A1 Quaternary ammonium salt prodrugs
11/14/2012CN102775349A Preparation method for bulleyaconitine A
11/14/2012CN102775348A Naphthalimide derivative and application thereof
11/14/2012CN101535268B Tyrosine kinase inhibitors
11/08/2012US20120283243 Spiroindoline Modulators of Muscarinic Receptors
11/08/2012DE102011100831A1 Preparing (1R,6S)-1-(3,4-dichlorophenyl)-6-(methoxymethyl)-4-azabicyclo(4.1.0)heptane) in optically active form, useful for treating depression, comprises converting enyne compounds to azabicyclo(4.1.0)hept-en-yl-methanol derivatives
11/07/2012EP2520571A1 2-azatriphenylene materials for organic light emitting diodes
11/07/2012CN102146057B C19-diterpenoid alkaloid, preparation method of C19-diterpenoid alkaloid, medical composite with C19-diterpenoid alkaloid used as active ingredient and application of medical composite
11/07/2012CN102140079B Novel yunaconitine and preparation method thereof as well as pharmaceutical composition based on compound as active ingredient and application of novel yunaconitine
11/06/2012US8304547 Azolecarboxamide compound or salt thereof
11/06/2012US8304423 Modulators of muscarinic receptors
11/01/2012WO2012149113A1 Method of treating dyskinesia
11/01/2012WO2012147330A1 Compound with acridan ring structure, and organic electroluminescent element
11/01/2012WO2012145981A1 Adamantane or adamantane-like compounds as antitumor agents
11/01/2012CA2834735A1 Method of treating dyskinesia
10/2012
10/31/2012EP2517706A2 Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
10/30/2012US8299088 Compositions and methods for treating cancer
10/30/2012US8298512 Methods of determining β-III tubulin expression
10/26/2012WO2012143661A1 Method for quantifying living bacteria in a liquid medium
10/25/2012US20120268706 Compounds and liquid-crystalline medium
10/24/2012CN102746227A Dimemorfan phosphate crystal form II and preparation method thereof, and pharmaceutical composition
10/24/2012CN102746218A Compounds and liquid crystalline medium
10/24/2012CN102744056A Ti-V loaded aluminum-pillared montmorillonite heterogeneous catalyst and application thereof
10/23/2012US8293907 Preparation of saturated ketone morphinan compounds by catalytic isomerization
10/23/2012US8293899 Ketone transfer hydrogenation of stereoisomerically enriched 3-heteroaryl-3-oxocarboxylic esters by reducing 3-heteroaryl-3-hydroxycarboxylic esters in the presence of a ruthenium-containing catalyst, an amine and formic acid and/or formates
10/23/2012CA2523178C Materials and methods to potentiate cancer treatment
10/18/2012WO2012141249A1 Organic electroluminescent element
10/17/2012CN102731399A Preparation method of high-purity 3-methoxy-9 alpha, 13 alpha, 14 alpha morphinan hydrochloride
10/17/2012CN102731398A Extraction separation preparation method of isocorydione having anticancer activity
10/17/2012CN102731397A Preparation method of compound isocorydione having anticancer activity
10/17/2012CN102731396A Polyamine naphthalimide compounds and application of same in preparation of pharmaceutical preparation
10/17/2012CN101857569B Organic fluorescent gel compound based on anhydride naphthalene
10/16/2012CA2570461C Process for the preparation of gabapentin
10/16/2012CA2561635C New crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
10/11/2012US20120258981 Process for the Synthesis of Quaternary Amine Compounds
10/10/2012CN102718710A Morphinan compounds
10/10/2012CN102718709A Novel method for preparing amonafide
10/10/2012CN102718708A Novel nitrogen-containing heteroaryl compounds and methods of use thereof
10/10/2012CN101341125B New phenanthridine derivatives as bradykinin antagonists
10/04/2012US20120252815 Inhibitors of sphingosine kinase
10/03/2012EP2505579A2 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof
10/03/2012EP2505578A2 Methods and Compounds for Producing Dipeptidyl Peptidase IV Inhibitors and Intermediates thereof
10/03/2012CN1791401B Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
10/03/2012CN102712599A Novel sulfonic acid derivative compound and novel naphthalic acid derivative compound
10/03/2012CN102702101A Method for extracting huperzine A from huperzine serrate
10/03/2012CN102697777A Preparation method and new application of fuziline
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 110